Figure 2 illustrates the associations between PAX7 expression and tumor T, N, and M staging, pathological stage, OS events, HER2, PR, ER status, and PAM50 subtypes, demonstrating that PAX7 is significantly upregulated in breast cancer and linked to various clinical characteristics (p < 0.05). This evidence concerns the gene PAX7 and breast carcinoma.